my account  log out
 

Anti-SLC34A2 (Lifastuzumab)-VC-MMAE ADC

Create: 01/26/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:This ADC product is comprised of an anti-SLC34A2 monoclonal antibody conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-slc34a2-86.htm
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer246
Feb 01 2023 GVBE Buffer250
Feb 01 2023 GVB++ (with Ca and Mg) Buffer255
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)246
Aug 30 2019Anti-HSV-2 gH Antibody435
Aug 30 2019Anti-L. major LPG Antibody521
Aug 30 2019Anti-DENV-1 Antibody427
Aug 30 2019Anti-BPV-1 L1 Antibody444
Aug 30 2019Anti-H3N2 HA Antibody424
Aug 30 2019Anti-EIAV env Antibody453

return back

Copyright © toextrade Inc. All rights reserved. Contact us